SEFILBI Trademark
Trademark Overview
On Wednesday, January 31, 2018, a trademark application was filed for SEFILBI with the United States Patent and Trademark Office. The USPTO has given the SEFILBI trademark a serial number of 79228272. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, October 2, 2023. This trademark is owned by NOVARTIS AG. The SEFILBI trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
General Information
Serial Number | 79228272 |
Word Mark | SEFILBI |
Filing Date | Wednesday, January 31, 2018 |
Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
Status Date | Monday, October 2, 2023 |
Registration Number | 5537980 |
Registration Date | Tuesday, August 14, 2018 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 29, 2018 |
Trademark Statements
Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | H - NOT AVAILABLE |
Class Status Date | Monday, October 2, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | NOVARTIS AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | NOVARTIS AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | NOVARTIS AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Trademark Events
Event Date | Event Description |
Sunday, October 22, 2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
Sunday, October 22, 2023 | DEATH OF INTERNATIONAL REGISTRATION |
Saturday, October 6, 2018 | NOTIFICATION PROCESSED BY IB |
Wednesday, September 19, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
Wednesday, September 19, 2018 | FINAL DISPOSITION PROCESSED |
Thursday, September 13, 2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
Tuesday, August 14, 2018 | REGISTERED-PRINCIPAL REGISTER |
Saturday, June 2, 2018 | NOTIFICATION PROCESSED BY IB |
Tuesday, May 29, 2018 | PUBLISHED FOR OPPOSITION |
Wednesday, May 16, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, May 16, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, May 9, 2018 | NOTICE OF PUBLICATION |
Thursday, April 26, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 25, 2018 | ASSIGNED TO EXAMINER |
Saturday, March 17, 2018 | APPLICATION FILING RECEIPT MAILED |
Tuesday, March 13, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, March 12, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Thursday, March 8, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |